FRM
Fox Run Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,363
| Closed | -$245K | – | 293 |
|
|
2020
Q1 | $245K | Buy |
+3,363
| New | +$245K | 0.58% | 52 |
|
|
2019
Q1 | – | Sell |
-3,007
| Closed | -$408K | – | 595 |
|
|
2018
Q4 | $408K | Buy |
+3,007
| New | +$408K | 0.22% | 175 |
|
|
2017
Q4 | – | Sell |
-1,900
| Closed | -$259K | – | 781 |
|
|
2017
Q3 | $259K | Buy |
+1,900
| New | +$259K | 0.07% | 540 |
|